ICYMI last night the FDA rejected a breast cancer drug from Immunomedics a biotech that was hoping for its first approval in 37 years. adamfeuerstein reports httpswww.statnews.com20190117fdarejectsimmunomedicsbreastcancerdrugÂ

ICYMI last night, the FDA rejected a breast cancer drug from Immunomedics, a biotech that was hoping for its first approval in 37 years. ⁦@adamfeuerstein⁩ reports: https://www.statnews.com/2019/01/17/fda-rejects-immunomedics-breast-cancer-drug/ …

10:47 EST 18 Jan 2019 | STAT

ICYMI last night, the FDA rejected a breast cancer drug from Immunomedics, a biotech that was hoping for its first approval in 37 years. ⁦ @adamfeuerstein⁩ reports: https://www.statnews.com/2019/01/17/fda-rejects-immunomedics-breast-cancer-drug/ …

More From BioPortfolio on "ICYMI last night, the FDA rejected a breast cancer drug from Immunomedics, a biotech that was hoping for its first approval in 37 years. ⁦@adamfeuerstein⁩ reports: https://www.statnews.com/2019/01/17/fda-rejects-immunomedics-breast-cancer-drug/ …"